SPOTLIGHT -
Young Children Benefit from 3 Doses of Pfizer-BioNTech COVID-19 Vaccine
The vaccine was 73.2% effective in children aged 6 months to 4 years when administered during the Omicron-dominant phase.
COVID-19 Vaccine Included in Updated CDC Vaccine Schedule for Children and Adolescents
The updated vaccine schedule includes vaccinations for influenza, pneumococcal disease, measles, mumps, and rubella (MMR) and COVID-19.
Investment in mRNA Technology Is Driving Force for Moderna’s Vaccine Pipeline
The company is utilizing this platform to address new COVID-19 variants, combination vaccines, and potentially prevent HIV.
